Waging the War for Talent: Do Recruitment and Screening Strategies Raise Employee Performance?

We use data from the Multi-City Study of Urban Inequality to provide an empirical answer to the question, “Do recruitment and screening strategies raise employee performance?” Our approach differs from previous empirical work in that we allow for changes in screening behavior to accompany changes in recruitment behavior. In the end, our results are consistent with those of the previous literature that ignores the auxiliary effect of recruitment through screening, in that we find no effect of recruitment methods on worker performance

Doing the Right Jobs Right: Managers’ Attributes and Activities at Borders

[Excerpt] This article starts with a simple value proposition: that companies can save large sums and gain competitive advantage by utilizing more fully their own data on the determinants of profit. In this article, we describe how we used a variety of statistical methods (correlations, simple regressions, multiple regressions, and decompositions) to help one company, Borders, gain competitive advantage by learning from itself

Looking forward to a safer future: The new WHO guidelines for safe surgery

Each year in Australia there are approximately 2 million hospital admissions for surgical services (Australia’s Health, 2008) and this number is set to grow significantly, with forecasts of at least a 22% increase by 2021 (Birrell, Hawthorne & Rapson, 2003). Surprisingly, for such a high-risk high-volume specialty, we have very little data on perioperative adverse events. This lack of even basic data means that we are unable to track event rates, leaving us oblivious to the full extent of the problem. Research on intraoperative adverse events tells us that the rate of major complications is between 3-16%, with a mortality rate of 0.4-0.8%. (Kable, Gibbered & Spigelman, 2002; Gawande et al, 1999). Applying the lowest of these rates (3% & 0.4%) to Australia’s surgical population reveals that a staggering 60,000 patients annually suffer significant complications, with 8000 patients dieing during or immediately after surgery as a result of adverse events. This is indeed a significant number, and given that the research indicates that nearly half of these events are preventable (Kable, Gibbered & Spigelman, 2002; Gawande et al, 1999), one that clearly needs addressing. This paper will review the research on perioperative safety and adverse events and examine some of the safety strategies put forward in the new World Health Organizations (WHO) Guidelines for Safe Surgery. These guidelines were developed for the WHO by renowned perioperative safety champion Dr Atul Gawande and contain recommendations for ‘safer surgery practices’ that have been demonstrated to reduce adverse events

Remarks: The Declining Role of Outside Counsel in Enhancing Ethical Conduct by Corporations

Judge Rakoff’s remarks from the seventh annual Berle Symposium, held May 26–27, 2015 at Seattle University School of Law

Utilising the Clinical Excellence Commission’s Performance Indicators for Quality Use of Medicines

Like other aspects of health care, Quality Use of Medicine (QUM) can be considered in terms of structures, processes and outcomes. These components of QUM can be measured with performance indicators. This poster describes the Clinical Excellence Commissions (CEC) new performance indicators and their use in a warfarin practice improvement project. Aim: - To measure performance indicators in order to; Comprehensively audit warfarin therapy. - Benchmarking current practices. - Identify opportunities for practice improvement. - Measure practice change\u3e Method: Auditing structures, processes, and outcomes requires different tools and methods. For this project, the following tools were utilised; - The CEC Medication Safety Self Assessment for Antithrombotic Therapy in Australian Hospitals tool (MSSA-AT) was selected to provide qualitative data on hospital structure, culture, systems, policies, procedures and activities. - The CEC and NSW TAG Indicators for Quality Use of Medicines in Australian Hospitals were used to review processes. These indicators provided quantitative data regarding the impact and effectiveness of systems, policies and procedures. Indicators from Australia Council of Health Care Standards (ACHS) provided quantitative data related to patient outcomes. Results: Together, the tools provided a comprehensive evaluation of warfarin therapy at St Vincents Private Hospital. The MSSA-AT provided a baseline measure of performance, a benchmark of practices, and numerous areas for practice improvement. The CEC’s process indicators provided a picture of current practices. This data, when benchmarked, identified strengths and opportunities and the ongoing measurement of these indicators will provide ongoing evidence of practice change. The ACHS outcomes date provided evidence that, although room for improvement, outcomes remained comparable with national data. Conclusion: Using performance indicators enabled a comprehensive review of clinical practice by providing information from a variety of sources about different aspects of therapy. This information can then facilitate the practice improvement process

Felix Frankfurter: Liberal Lawyer, Conservative Justice

The Hon. Jed S. Rakoff gave the first presentation at the conference, providing an introduction to Justice Felix Frankfurter by describing some of his accomplishments and situating his tenure on the Supreme Court in the context of the Court’s historically conservative orientation